期刊
PEDIATRIC BLOOD & CANCER
卷 59, 期 5, 页码 934-938出版社
WILEY-BLACKWELL
DOI: 10.1002/pbc.24103
关键词
Kasabach-Merritt; kaposiform hemangioendothlioma; propranolol; treatment; tufted angioma; vascular tumor
资金
- National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS/NIH) [K23AR060274]
Propranolol is a non-selective beta-adrenergic antagonist successfully used in a case of kaposiform hemangioendothelioma (KHE) associated with KasabachMerritt phenomenon (KMP). We report 11 patients treated with propranolol for KHE and the related variant tufted angioma (TA), six of whom also had KMP. The varied responses to treatment, with only 36% responding in our series, demonstrate the need for further study of this medication before routine use for these indications. Pediatr Blood Cancer 2012; 59: 934938. (C) 2012 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据